Introducing CLOUD-6™
CLOUD-6™ is a non-nicotine compound that provides adult users with feelings of fulfillment that are almost identical to those of conventional nicotine vaping devices.
CLOUD-6™ is a synthetically derived molecule that is structurally similar to, but chemically different from, other vaping alkaloids.
CLOUD-6™ is not made or derived from tobacco or nicotine and does not consist of or contain nicotine from any source.
CLOUD-6™ is intended only as a satisfying alternative for adult tobacco users and vapers.
Benefits
May be exempt from excise taxes in certain states
Not subject to FDA premarket authorization (commonly known as PMTA)
Delivers similar satisfaction as traditional nicotine products
Landing Regulatory Status
Since CLOUD-6 ™ does not contain nicotine, and is not derived from tobacco, and is not a component or part of a tobacco product, it does not fall under the regulatory purview of the FDA’s Center for Tobacco Products.
CLOUD-6 ™ does not meet the definition of nicotine as stated in the Family Smoking Prevention and Tobacco Control Act, is not a salt or complex of nicotine, and is not itself derived from nicotine or tobacco; accordingly, CLOUD-6 ™ is not subject to FDA tobacco requirements.
CLOUD-6 ™ is not recognized as a drug in the official United States Pharmacopoeia and is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.
CLOUD-6 ™ products are not required to obtain FDA premarket authorization (often known as a PMTA) required for new tobacco products, like e-cigarettes.
CLOUD-6™ does not contain nicotine nor is derived from tobacco and thus does not fall subject as a tobacco product. CLOUD-6™ therefore resides outside of the regulatory purview of the FDA’s Center for Tobacco Products.
CLOUD-6 ™ does not meet the definition of nicotine and is not synthesized from nicotine or tobacco and therefore, CLOUD-6 ™ is not subject to the tobacco requirements outlined by the FDA.
